The potential therapeutic benefits of cannabidiol (CBD) require further study. Here, we report a triple-blind (participant, investigator, and outcome assessor) placebo-controlled crossover study in which 62 hypertensive volunteers were randomly assigned to receive the recently developed DehydraTECH2.0 CBD formulation or a placebo. This is the first study to have been conducted using the DehydraTECH2.0 CBD formulation over a 12-week study duration. The new formulation’s long-term effects on CBD concentrations in plasma and urine, as well as its metabolites 7-hydroxy-CBD and 7-carboxy-CBD, were analyzed. The results of the plasma concentration ratio for CBD/7-OH-CBD in the third timepoint (after 5 weeks of use) were significantly higher than in the second timepoint (after 2.5 weeks of use; p = 0.043). In the same timepoints in the urine, a significantly higher concentration of 7-COOH-CBD was observed p < 0.001. Differences in CBD concentration were found between men and women. Plasma levels of CBD were still detectable 50 days after the last consumption of the CBD preparations. Significantly higher plasma CBD concentrations occurred in females compared to males, which was potentially related to greater adipose tissue. More research is needed to optimize CBD doses to consider the differential therapeutic benefits in men and women.

The most common type of periodontal disease is chronic periodontitis, an inflammatory condition caused by pathogenic bacteria in subgingival plaque. The aim of our study was the development of a real-time PCR test as a diagnostic tool for the detection and differentiation of five periodontopathogenic bacteria, Aggregatibacter actinomycetemcomitans, Porphyromonas gingivalis, Tannerella forsythia, Prevotella intermedia, and Treponema denticola, in patients with periodontitis. We compared the results of our in-house method with the micro-IDent^® semiquantitative commercially available test based on the PCR hybridization method. DNA was isolated from subgingival plaque samples taken from 50 patients and then analyzed by both methods. Comparing the results of the two methods, they show a specificity of 100% for all bacteria. The sensitivity for A. actinomycetemcomitans was 97.5%, for P. gingivalis 96.88%, and for P. intermedia 95.24%. The sensitivity for Tannerella forsythia and T. denticola was 100%. The Spearman correlation factor of two different measurements was 0.976 for A. actinomycetemcomitans, 0.967 for P. gingivalis, 0.949 for P. intermedia, 0.966 for Tannerella forsythia, and 0.917 for T. denticola. In conclusion, the in-house real-time PCR method developed in our laboratory can provide information about relative amount of five bacterial species present in subgingival plaque in patients with periodontitis. It is likely that such a test could be used in dental diagnostics in assessing the efficacy of any treatment to reduce the bacterial burden.

Due to cannabidiol’s health benefits and absence of serious side effects, its use is constantly growing. This is a survey-based cross-sectional study that was conducted to determine Croatian pharmacists’, physicians’, and students’ knowledge and attitudes about cannabidiol (CBD). Two questionnaires were created, one for students and the other for physicians and pharmacists. Our participants (in total 874: 473 students and 401 physicians and pharmacists) generally had positive attitudes towards CBD therapy as approximately 60% of them believe that CBD treatment is generally efficacious. Participants had positive attitudes toward the therapeutic value of CBD, especially pharmacists and pharmacy students (63.8% and 72.2%, respectively). Pharmacists were significantly more convinced that CBD could reduce the use of opioids prescribed for chronic pain (p < 0.05). Only 17.5% of students had read scientific papers about CBD, compared to a significantly higher percentage of physicians and pharmacists (43.0% and 47.8%, respectively) (p < 0.05). This study revealed a gap in knowledge regarding CBD, since 89.3% of pharmacists and physicians, as well as 84.8% of students, believe they need more education about CBD. We conclude that it is important to improve the educational curricula so that medical professionals can recommend CBD use to their patients when needed.

Objectives: Periodontal disease is a chronic inflammatory condition that significantly impacts oral and systemic health. Age, gender, systemic diseases, sleep disordered breathing, and specific periodontopathogenic bacteria are the risk factors for developing periodontal disease. This study aimed to assess the presence of five periodontopathogenic bacteria (Aggregatibacter actinomycetemcomitans, Porphyromonas gingivalis, Prevotella intermedia, Tannerella forsythia, and Treponema denticola) in a sample and analyze their association with variables such as age, gender, systemic disorders, and snoring.Materials and methods: This cross-sectional study included 149 adult patients (62 male and 87 female) with clinical symptoms of localized chronic periodontitis. Participants filled out a questionnaire to provide data on their sociodemographic and clinical characteristics, and the presence of five periodontopathogenic bacteria in subgingival plaque samples was analyzed with real-time PCR.Results: Statistically significant results were obtained regarding the association between age and periodontopathogenic bacteria. Positive results for Porphyromonas gingivalis and Tannerella forsythia were associated with ages between 41 and 60, and over 60 . For the bacterium Aggregatibacter actinomycetemcomitans, the statistical results in the distribution of patients regarding snoring were borderline significant. More individuals who did not snore had positive results.Conclusions: Older age had the greatest impact, and the majority of patients positive for the tested bacteria were females.

Nicotine is the main psychoactive component of tobacco and is considered to be the main substance responsible for the development of tobacco addiction. The main enzyme responsible for nicotine metabolism, CYP2A6, catalyzes the conversion of nicotine to cotinine and the subsequent metabolism of cotinine to trans-3′-hydroxycotinine. CYP2A6 activity is known to be modulated by various compounds, such as quercetin. This repeated-measures study examined the effects of short-term quercetin supplementation on urinary nicotine metabolism biomarkers in adult users of conventional and alternative nicotine products. Seventy-two participants completed a two-week study protocol involving first-morning urine collection at four time points: baseline, immediately after three days of quercetin supplementation (500 mg/day), seven days after supplementation, and ten days after supplementation. Urinary nicotine, cotinine, and trans-3′-hydroxycotinine concentrations were measured, and the nicotine metabolite ratio was calculated as trans-3′-hydroxycotinine/cotinine. Repeated-measures analysis of variance was used to evaluate biomarker changes over time according to sex, nicotine product type, and self-reported nicotine consumption intensity. Quercetin supplementation did not consistently alter nicotine metabolism biomarkers, while a descriptive increase in median urinary nicotine concentration after supplementation was observed in participants reporting lower daily nicotine consumption compared with other groups. These findings suggest that further studies are warranted to better clarify the effects of quercetin on nicotine metabolism across different levels of nicotine exposure.

Background/Objectives: Periodontitis is a chronic inflammatory disease characterized by complex interactions between periodontal pathogens and the host immune response. Pro-inflammatory cytokines, particularly interleukins, may influence bacterial colonization and disease expression, but their association with specific periodontal pathogens remains unclear. This study investigated the associations between single-nucleotide polymorphisms in IL-1A, IL-1B, and TNFA and the presence of key periodontopathogenic bacteria in patients from Croatia. Methods: A cross-sectional study included 63 participants. Genotypes were determined, and subgingival plaque samples were analyzed for Aggregatibacter actinomycetemcomitans, Porphyromonas gingivalis, Prevotella intermedia, Tannerella forsythia, and Treponema denticola using real-time PCR. Multivariable logistic regression models assessed associations between cytokine gene polymorphisms and periodontopathogenic bacteria presence, adjusting for age, gender, smoking status, and the presence of systemic diseases. Results: Among participants (median age 57.0 years, IQR 43.5–67.0; 58.7% female), P. intermedia (87.3%), T. forsythia (85.7%), and T. denticola (69.8%) were the most prevalent pathogens. The IL-1A CC genotype significantly increased the odds of P. gingivalis (OR = 5.54; p = 0.009) and T. denticola (OR = 3.77; p = 0.041) presence. The IL-1B CC genotype was independently associated with T. forsythia (OR = 8.48; p = 0.026). No significant associations were observed for TNFA polymorphism. Model performance ranged from moderate to good (AUC up to 0.89). Conclusions: Genetic variants in IL-1A and IL-1B may influence periodontal bacterial colonization, while demographic and lifestyle factors showed limited impact. Further studies in larger cohorts are warranted.